The Clorox Company (NYSE:CLX) Shares Sold by L. Roy Papp & Associates LLP

L. Roy Papp & Associates LLP cut its holdings in The Clorox Company (NYSE:CLXFree Report) by 0.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 15,770 shares of the company’s stock after selling 101 shares during the quarter. L. Roy Papp & Associates LLP’s holdings in Clorox were worth $2,561,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wealth Group Ltd. purchased a new stake in shares of Clorox in the third quarter valued at about $231,000. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Clorox by 256.4% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,112 shares of the company’s stock worth $181,000 after purchasing an additional 800 shares during the last quarter. Ritholtz Wealth Management purchased a new stake in Clorox in the 3rd quarter valued at approximately $214,000. Koshinski Asset Management Inc. grew its holdings in Clorox by 22.6% during the 3rd quarter. Koshinski Asset Management Inc. now owns 4,402 shares of the company’s stock valued at $717,000 after buying an additional 811 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in Clorox during the 3rd quarter valued at $240,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX stock opened at $148.47 on Wednesday. The company’s fifty day simple moving average is $160.68 and its 200-day simple moving average is $159.16. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a market cap of $18.38 billion, a PE ratio of 40.56, a P/E/G ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm earned $2.16 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CLX shares. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Finally, Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox currently has an average rating of “Hold” and a consensus target price of $158.21.

Check Out Our Latest Stock Analysis on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.